Psychiatric morbidity and protracted symptoms after COVID-19

• Published in: Psychiatry research Vol. 295; p. 113604
• Main Authors: Poyraz, Burç Çağrı, Poyraz, Cana Aksoy, Olgun, Yeşim, Gürel, Özge, Alkan, Sena, Özdemir, Yusuf Emre, Balkan, İlker İnanç, Karaali, Rıdvan
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01.01.2021
• Subjects: Adult; Anxiety - epidemiology; Anxiety - etiology; Anxiety disorders; COVID-19; COVID-19 - complications; COVID-19 - epidemiology; COVID-19 - physiopathology; Depression; Depression - epidemiology; Depression - etiology; Female; Follow-Up Studies; Humans; Male; Middle Aged; Protracted symptoms; PTSD; Stress Disorders, Post-Traumatic - epidemiology; Stress Disorders, Post-Traumatic - etiology; COVID-19; PTSD; Depression; Protracted symptoms; Anxiety disorders
• ISSN: 0165-1781; 1872-7123; 1872-7123
• DOI: 10.1016/j.psychres.2020.113604

•We studied the psychiatric morbidity and the protracted symptoms in recently recovered COVID-19 patients.•We also looked at potential factors that might influence psychiatric morbidity.•Significant symptoms of posttraumatic stress, anxiety and depression were found.•PTSD symptom severity was the sole independent predictor of the presence of protracted symptoms. We investigated the psychiatric symptomatology and the protracted symptoms in patients who had recovered from the acute COVID-19 infection. Two hundred and eighty-four patients completed a web-based or a paper survey on socio-demographic and clinical data. The psychiatric status was assessed using Impact of Events Scale-Revised (IES-R), Hospital Anxiety and Depression Scale (HADS), Pittsburgh Sleep Quality Index (PSQI), and MINI suicidality scale. Patients completed a checklist for the protracted symptoms that were experienced after the acute infection. After a mean of almost 50 days following the diagnosis, 98 patients (34.5%) reported clinically significant PTSD, anxiety, and/or depression, with PTSD being the most common condition reported (25.4%). One hundred and eighteen patients (44.3%) reported one or more protracted symptom(s). Predictors of PTSD symptom severity were the female gender, past traumatic events, protracted symptoms, stigmatization, and a negative view on the COVID-19 pandemic. PTSD symptom severity was the sole independent predictor of the protracted symptoms. Our results suggest that COVID-19 patients are prone to substantial psychological distress in the first few months after the infection. The protracted symptoms were frequent in this period, and these were closely related to the posttraumatic symptoms.